Department of Surgery Department of Surgery
College of Medicine | USA Health System | Care Centers | Maps
Residents | Students | text only
  Grants 2003-2004
  Grants 2004-2005
Research
 

STUDY COORDINATORS

Ms. Cathy Blache
Pager: 582.4653
Phone: 251.471.7988-VM* (77495)
E-mail: cblache@usouthal.edu

Ms. Kelly Taylor
Pager: 694-5297
Phone: 251.471.7988
E-mail: kbose@usouthal.edu

 

CURRENT TRIALS

62977 Flammacerium
Sponsor: Synthes
Title: Cerium Nitrate/Silver Sulfadiazine Cream vs Silver Sulfadiazine Cream Alone in the Treatment of Burn Patients
PI: Luterman, Frye, Dyess
Enrollment Status: OPEN

63507 Bayer SST
Sponsor:
Bayer
Title: IV Bay 12-8039 (Moxifloxacin) Followed By Oral Moxifloxacin Compared To Iv Piperacillin/Tazobactam Followed By Oral Amoxicillin/Clavulanic Acid In The Treatment Of Complicated Skin And Skin Structure Infections
PI: Luterman, Frye, Dyess
Enrollment Status: OPEN

62514 MerckDiabetic SST
Sponsor: Merck
Title: A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerabiliity, of Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in Adults
PI: Luterman, Frye, Dyess
Enrollment Status: CLOSED

63536 Merck IA
Sponsor: Merck
Title: A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability, of Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Intra-abdominal Infections in Hospitalized in Adults
PI: Gonzalez, Dyess, Luterman, Frye, Hodge, Rodning
Enrollment Status: CLOSED

63557 Merropenem
Sponsor: Astra-Zeneca
Title: A Multicenter, Randomized, Double Blind, Comparative Trial of Intravenous MERREM™ (meropenem, ICI 194,660) vs PRIMAXIN® (imipenem-cilastatin) in the Treatment of Hospitalized Subjects with Complicated Skin and Skin Structure Infections
PI: Luterman, Frye, Dyess
Enrollment Status: CLOSED

63560 Versicor
Sponsor: Versicor, Inc
Title: Phase II, Randomized, Open-label, Multi-Center Study to Evaluate the Safety and Efficacy of Dalbavacin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections with Suspected or Confirmed Gram-Positive Bacterial Pathogens
PI: Luterman, Gonzalez, Frye, Hodge, Rodning
Enrollment Status: OPEN

63589 Mediwound
Sponsor: Mediwound
Title: Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
PI: Luterman, Frye, Dyess
Enrollment Status: OPEN

Valdecoxib
Sponsor: Pfizer
Title: Clinical Protocol for a Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for the Treatment of Post-Surgical Pain from Laparoscopic Cholecystectomy Surgery.
PI: Hodge, Gonzalez
Enrollment Status:
CLOSED

 

PENDING TRIALS

 

Tigecycline (GAR-936) in resistant pathogens (MRSA/VRE)
PI: Luterman, Frye, Dyess, Gonzalez, Hodge, Rodning

Tigecycline (GAR-936) in resistant pathogens (Emergency Use)
PI: Luterman, Frye, Dyess, Gonzalez, Hodge, Rodning

Tigecycline (GAR-936) in resistant pathogens (Gram Negative)
PI: Luterman, Frye, Dyess, Gonzalez, Hodge, Rodning

Xigris for Less Severe Sepsis
PI: Gonzalez, Hodge, Rodning

LevoFloxacin with Metronidazole compared to Zosyn in Complicated Appendicitis
PI: Hodge, Gonzalez, Rodning

Epoetin Alfa in Critically Ill Subjects
PI: Luterman, Gonzalez, Hodge, Rodning

Valacyclovir in recurrent peripheral Vestibular Neuropathy
PI: Gacek

Medi-522 Phase II Prostate Cancer Trial
PI: Boullier

E5564 Lipid Antagonist in Severe Sepsis
PI: Gonzalez, Hodge, Rodning

Tacrolimus in Renal Transplant Patients
PI: Scantlebury, Magnone
 
CUBICIN™ For Complicated Post-Surgical Wound Infections
PI: Luterman
Co-Inv: Frye, Gonzalez, Rodning, Dyess, Hodge
 
An Open-Label, Non-comparative, Multicenter, Emergency -Use Protocol Administering Tigecycline for the treatment of Subjects with Infections due to Resistant Pathogens
PI: Luterman
Co-Inv: Frye, Gonzalez, Rodning, Dyess, Hodge
 
Silicone-Filled Breast Implant Adjunct Clinical Study 4
PI: Harris
 
Daptomycin Penetration in Serum and Tissue of Patients with Extensive Burns: A Pharmacokinetic Analysis
PI: Frye
Co-Inv: Luterman
 
 
LINKS
 
New IRB Initiatives
 
Global Research
 
USA Clinical Research
 
 
 
 
 
 
 
University of South Alabama - Mobile Alabama 36688-0002 / 1 (251) 460-6101
For questions or comments Contact Us
Last date changed: July 31, 2007 10:58 AM
http://www.southalabama.edu/usahealthsystem/surgery/research.html